Description |
1 online resource : illustrations (colour) |
Contents |
<Ol> <li>Platelets and arterial disease -- initiation, progression and destabilization of atherosclerotic vascular disease</li> <p> <li>Platelet physiology and pharmacology -- relevant considerations for patient care</li> <p> <li>The development of dual antiplatelet therapy -- physiologic and clinical implications of multiple pathway inhibition of platelet function</li> <p> <li>Acute coronary syndromes and percutaneous coronary intervention -- current recommendations for dual antiplatelet therapy. Are guidelines reflecting the data?</li> <p> <li>Peripheral arterial disease -- a different kind of arterial disease? The role of antiplatelet therapy in prevention and treatment of limb ischemia</li> <p> <li>Cerebrovascular disease -- what is the role of DAPT for prevention and treatment of ischemic stroke?</li> <p> <li>Competing risks in DAPT duration of therapy -- the case for shorter treatment</li> <p> <li>DAPT may prevent coronary ischemic events beyond one year -- the case for extended DAPT treatment</li> <p> <li>How to integrate risk of bleeding and ischemic events in clinical medicine? The role of risk scores </li> <p> <li>Moving from DAPT to monotherapy based on P2Y12 receptor blockade -- why it could be a novel paradigm?</li> <p> <li>The conundrum of simultaneous antiplatelet and antithrombotic therapy -- how to resolve it?</li> <p> <li>A look to the future </li> </ol> |
Subject |
Coronary heart disease -- Treatment.
|
|
Peripheral vascular diseases -- Treatment
|
|
Blood platelets.
|
|
Blood Platelets
|
|
Blood platelets
|
|
Coronary heart disease -- Treatment
|
|
Peripheral vascular diseases -- Treatment
|
Form |
Electronic book
|
Author |
Brener, Sorin, editor
|
ISBN |
9780128205372 |
|
0128205377 |
|